Hospitalizations for alcoholic liver disease during the COVID-19 pandemic increased more for women, especially young women, compared to men

Table 1 Trends for alcoholic liver disease admissions pre-COVID and during COVID-19, n (%)

Variable	Total (n = 1378)	COVID-19 period (n = 700)	Pre-COVID-19 period (n = 678)	P value
Age (yr)	53.9 ± 13.1	53.1 ± 12.9	54.7 ± 13.2	0.025
Gender				0.002
Female	473 (34.3%)	267 (38.1%)	206 (30.4%)
Male	905 (65.7%)	433 (61.9%)	472 (69.6%)
Race				0.628
Black or African American	168 (12.2%)	91 (13.0%)	77 (11.4%)
White or Caucasian	1112 (80.7%)	559 (79.9%)	553 (81.6%)
Diagnosis name				0.274
Alcoholic cirrhosis of liver with ascites	491 (35.6%)	246 (35.1%)	245 (36.1%)
Alcoholic cirrhosis of liver without ascites	336 (24.4%)	164 (23.4%)	172 (25.4%)
Alcoholic fatty liver	43 (3.1%)	20 (2.9%)	23 (3.4%)
Alcoholic fibrosis and sclerosis of liver	1 (0.1%)	0 (0.0%)	1 (0.1%)
Alcoholic hepatic failure with coma	4 (0.3%)	3 (0.4%)	1 (0.1%)
Alcoholic hepatic failure without coma	141 (10.2%)	79 (11.3%)	62 (9.1%)
Alcoholic hepatitis with ascites	85 (6.2%)	52 (7.4%)	33 (4.9%)
Alcoholic hepatitis without ascites	205 (14.9%)	105 (15.0%)	100 (14.7%)
Alcoholic liver disease, unspecified	72 (5.2%)	31 (4.4%)	41 (6.0%)
Discharge disposition				0.034
Expired	57 (4.2%)	34 (4.9%)	23 (3.4%)
Home or self-care	832 (60.6%)	412 (59.1%)	420 (62.1%)
Home-health care service	154 (11.2%)	86 (12.3%)	68 (10.1%)
Hospice/home	30 (2.2%)	16 (2.3%)	14 (2.1%)
Hospice/medical facility	38 (2.8%)	14 (2.0%)	24 (3.6%)
Left against medical advice	47 (3.4%)	30 (4.3%)	17 (2.5%)
Rehab facility	29 (2.1%)	18 (2.6%)	11 (1.6%)
Short term hospital	58 (4.2%)	34 (4.9%)	24 (3.6%)
Skilled nursing facility	76 (5.5%)	35 (5.0%)	41 (6.1%)

COVID: Coronavirus disease.